variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
DCAF8-R317C,DCAF8,"Reported to cause axonal hereditary motor and sensory neuropathy in a dominant manner, with mild cardiomyopathy. Evidence for this may be weak: this report comes from a 2014 paper, Klein et al: http://www.ncbi.nlm.nih.gov/pubmed/24500646 and is recorded in ClinVar by OMIM: http://www.ncbi.nlm.nih.gov/clinvar/variation/133348/",High,Uncertain,Pathogenic,,"Heart and circulatory;Muscular, skeletal, and connective tissue;Nervous system",Dominant,Heterozygous,,,5,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
C3-R102G,C3,"This variant (also called C3F) is common in Europeans (10.2% allele frequency), and is associated with age-related macular degeneration. In the US, 1.5% of adults over 40 have the disease, but the incidence increases strongly with age (>15% in women over 80). Assuming an average lifetime risk of ~10%, heterozygous individuals have a ~13% risk and homozygous have ~20%.",Moderate,Likely,Pathogenic,0.15,Hearing and vision,Complex/Other,Heterozygous,4427677;17634448,rs2230199,3,chr19,6718387,C,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
MATN3-T303M,MATN3,"An Iceland study implicated this in causing increased osteoarthritis -- in particular, hand osteoarthritis. Because the variant is rare, the statistical significance of observations is weak. The authors estimate that individuals heterozygous for this variant have a 2.1-fold risk for hand osteoarthritis.",Moderate,Uncertain,Pathogenic,0.011,"Muscular, skeletal, and connective tissue",Unknown,Heterozygous,12736871,rs77245812,3,chr2,20202930,A,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
COL4A1-Q1334H,COL4A1,"This common variant has been associated with arterial stiffness and, in Japanese, a small increased risk of myocardial infarction (MI, a.k.a. heart attack). This last observation supported a dominant effect for this variant and, assuming a lifetime risk of 15% for MI, we estimate carriers have an additional risk of 0.5-3%.",Low,Likely,Pathogenic,0.32,Heart and circulatory,Dominant,Heterozygous,10334796;18077766;20031579,rs3742207,2,chr13,110818598,G,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
LMNB2-R215Q,LMNB2,"Carriers of this variant have increased susceptibility to acquired partial lipodystrophy (""Barraquer-Simons syndrome"", loss of fat in the upper body) -- this syndrome is quite rare, however, so even for carriers the chances of developing the syndrome is very low (less than 1%).",Low,Likely,Pathogenic,0.011,Other,Dominant,Heterozygous,16826530,rs61726481,1,chr19,2435150,T,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Homozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
WFS1-R611H,WFS1,"This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).",Low,Uncertain,Not Reviewed,0.4,Hearing and vision;Immune system;Metabolism,Recessive,Heterozygous,17603484;17719176;23257691,rs734312,1,chr4,6303354,A,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Homozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
CYP2C9-R144C,CYP2C9,"This variant, also called CYP2C9*2, is a pharmacogenetic variant that modulates sensitivity for Warfarin (due to reduced metabolism). This variant is associated with Caucasians. The FDA has approved reduced recommended Warfarin dosage based on the presence of this variant.",Moderate,Well-established,Pharmacogenetic,0.097,Drug response;Metabolism,Unknown,Heterozygous,8004131;15947090;17161452;17686967;19228618;19794411;19794412,rs1799853,3,chr10,96702047,T,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
rs1544410,,"rs1544410 is a Vitamin D Receptor (VDR) single nucleotide polymorphism. It is unlikely that it has functional significance because it is located in an intron (Liu et. al.), but it is in strong linkage disequilibrium with rs731236 (Dvornyk et al), which is located in an exon. ",Low,Uncertain,Pharmacogenetic,0.35,Other,Unknown,Heterozygous,,rs1544410,0,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
PRNP-M129V,PRNP,"This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.

",Low,Well-established,Protective,0.34,Other,Complex/Other,Heterozygous,18236005;19081515,rs1799990,0,chr20,4680251,G,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
CASP10-V410I,CASP10,"Reported to have a protective effect on breast cancer. If the lifetime risk of breast cancer is 12%, women with this variant may have a lower risk of 8-9% (30% less than average).",Low,Likely,Protective,0.047,Cancer,Dominant,Heterozygous,10412980;16251207,rs13010627,2,chr2,202074098,A,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
KCNJ11-K23E,KCNJ11,"This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.",Low,Likely,Protective,0.74,Metabolism,Unknown,Homozygous,17463246;17463248;20054294,rs5219,2,chr11,17409572,C,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
TOR1A-D216H,TOR1A,This SNP has been shown to be benign and play a protective role against Dystonia.  ,Low,Likely,Protective,0.1,Nervous system,Unknown,Heterozygous,18519876;19380705;20669276,rs1801968,1,chr9,132580901,G,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
IL7R-T244I,IL7R,"The reference genome variant for this allele has been associated with a slight increased risk of multiple sclerosis. Thus, this variant can be treated as a ""protective"" variant -- carriers of this variant are slightly less likely to have MS. Because the disease is rare and the effect of this variant is not very strong, the absolute decreased risk for carriers of this variant is less than .05% (less than 1 in 2000).",Low,Likely,Protective,0.21,Immune system;Nervous system,Unknown,Homozygous,12825072;17660530;17660816;17660817;21161391,rs6897932,0,chr5,35874575,T,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
IRS2-G1057D,IRS2,"a.k.a Gly1057Asp, insulin receptor substrate-2 IRS2. The rs1805097(G) allele is associated with the Gly, and the (A) allele with Asp. 
A longevity study concluded that rs1805097(A;A) individuals were about twice as likely to live over 85 y/o (odds ratio 2.03, CI:1.39-2.99, p = .0003). ",Low,Uncertain,Protective,0.23,Other,Unknown,Heterozygous,19887537,rs1805097,,chr13,110435231,T,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
TYR-R402Q,TYR,"This is a frequent pigmentation polymorphism in Europeans that affects function of the Tyrosinase gene. It is associated with blue instead of green eyes and sun sensitivity. For the most part this variant is benign, but many individuals with ocular albinism (which affects only the eyes) carry this variant along with another more severe variant in the same gene.",Low,Well-established,Benign,0.2,Hearing and vision,Complex/Other,Heterozygous,1820207;7704033;11284711;18326704;18488027;18488028;19533789,rs1126809,0,chr11,89017961,A,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
ARSA-N350S,ARSA,This common variant (HapMap 24.1% allele frequency) causes a loss of a glycosylation site (affecting the size of the protein when studied with gel electrophoresis) but does not affect enzyme activity or stability.,Low,Well-established,Benign,0.18,Other,Unknown,Heterozygous,2574462,rs2071421,,chr22,51064416,C,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
PKD1-A4059V,PKD1,Probably benign.,Low,Likely,Benign,0.057,Other,Unknown,Heterozygous,19686598,rs3209986,,chr16,2140554,A,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
FLT4-N149D,FLT4,"Other severe variants in this gene are implicated in causing Milroy Disease (primary lymphedema) in a recessive manner. Although this variant is rare (2.3% allele frequency), it is still common enough that it is highly unlikely to have a severe, high penetrance pathogenic effect.",Low,Likely,Benign,0.073,Blood,Unknown,Heterozygous,11292664,rs34221241,,chr5,180057293,C,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
CACNA1S-L458H,CACNA1S,Common polymorphism,Low,Likely,Benign,0.27,Other,Unknown,Homozygous,,rs12742169,,chr1,201052310,T,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
NEFL-S472Shift,NEFL,"Although a frameshift in this gene would be predicted to cause Charcot-Marie Neuropathy, this particular position appears to reflect a single base insertion error/mutation in the reference genome (in other words, normal individuals are always homozygous for a deletion at this position relative to reference). See chr8:24,811,060-24,811,080 annotations on UCSC.",Low,Likely,Benign,,Nervous system,Unknown,Homozygous,,rs11340767,,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
DMD-R2155W,DMD,Probably benign.,Low,Likely,Benign,0.027,Other,Unknown,Homozygous,9298822,rs1800273,,chrX,31986607,A,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
FBN2-S2580L,FBN2,"Probably benign -- initially associated with congenital contractual arachnodactyly, but later reports classify it as a nonpathogenic polymorphism.",Low,Uncertain,Benign,0.078,Anatomical and congenital,Dominant,Heterozygous,9714438;10633129;16835936;17345643,rs2291628,,chr5,127609633,A,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
RPGRIP1-A547S,RPGRIP1,"Probably benign. Implicated in causing autosomal recessive cone-rod dystrophy, but a later report found the same incidence in controls and concludes it is not causal.",Low,Uncertain,Benign,0.23,Hearing and vision,Complex/Other,Heterozygous,12920076;16272259,rs10151259,,chr14,21790040,T,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
MAPT-Q230R,MAPT,Common polymorphism.,Low,Uncertain,Benign,0.042,Other,Unknown,Heterozygous,15365985,rs63750072,,chr17,44060859,G,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
ERCC6-R1230P,ERCC6,Probably benign.,Low,Uncertain,Benign,0.07,Other,Unknown,Heterozygous,,rs4253211,,chr10,50678317,G,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
RP1-N985Y,RP1,"Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.",Low,Uncertain,Benign,0.35,Metabolism,Unknown,Homozygous,12764676;19364639,rs2293869,,chr8,55539395,T,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
PTCH1-P1315L,PTCH1,"Common polymorphism, presumed benign.",Low,Uncertain,Benign,0.3,Other,Unknown,Heterozygous,15712338,rs357564,,chr9,98209594,A,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
PKP2-L366P,PKP2,This variant is a benign polymorphism.  ,Low,Uncertain,Benign,0.22,Other,Unknown,Heterozygous,19955750,rs1046116,,chr12,33021934,G,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
RAPSN-R58C,RAPSN,Reported as non-pathogenic polymorphism. ,Low,Uncertain,Benign,0.078,Other,Unknown,Heterozygous,11791205,rs34312154,,chr11,47470345,A,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
TPCN2-G734E,TPCN2,Pigmentation allele.,Low,Uncertain,Benign,0.29,Other,Unknown,Homozygous,18488028,rs3829241,,chr11,68855363,A,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
SPTA1-A970D,SPTA1,"This variant, also called alpha-IIa, has been seen frequently in individuals with recessive Hereditary spherocytosis. This appears to be the result of linkage to alpha-LEPRA (a C>T substitution at position -99 of intron 30); A970D is later reported as functionally neutral.",Low,Uncertain,Benign,0.037,Blood,Unknown,Heterozygous,8844207;9067503;15384986;16150946,rs35948326,,chr1,158624528,T,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
WFS1-R456H,WFS1,Reported benign in ClinVar,Low,Uncertain,Benign,0.045,Other,Unknown,Heterozygous,,rs1801208,0,chr4,6302889,A,http://evidence.pgp-hms.org/genomes?display_genome_id=b9e23de67539a0360585040c02dae85ec921b387
